載入...
Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.
The site of action of aminoglutethimide (AG) has been investigated. An initial study was performed on 10 postmenopausal patients with advanced breast cancer who had taken 1000 mg AG per day and 20 mg hydrocortisone (HC) twice daily (b.d.) for greater than 3 months. There was a 15.5 +/- 5.6 s.e.-fold...
Na minha lista:
Main Authors: | , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Nature Publishing Group
1983
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2011397/ https://ncbi.nlm.nih.gov/pubmed/6221746 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|